Insulet (PODD) Receivables - Net (2010 - 2026)
Insulet's (PODD) quarterly Receivables - Net came in at $588.7 million in Q2 2026, up 92.13% on a YoY basis from $306.4 million in Q2 2025, and up 8.08% quarter-over-quarter from $544.7 million in Q1 2026.
Analysis
Insulet (PODD) Receivables - Net (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Receivables - Net for 17 consecutive years, with $588.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables - Net rose 92.13% year-over-year to $588.7 million; the trailing twelve-month figure through Jun 2026 stood at $588.7 million (up 92.13% YoY), and the FY2025 full-year result was $516.9 million, up 104.71% from the prior year.
- Receivables - Net grew to $588.7 million in Q2 2026 per PODD's latest filing, from $544.7 million in the prior quarter.
- Across five years, Receivables - Net topped out at $588.7 million in Q2 2026 and bottomed at $140.9 million in Q4 2022.
- Historically, Receivables - Net has averaged $272.4 million across 5 years, with a median of $244.6 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Receivables - Net gained 3.97% in 2023, then surged 104.71% in 2025.
- Over 5 years, Receivables - Net stood at $140.9 million in 2022, then soared by 70.55% to $240.3 million in 2023, then climbed by 5.08% to $252.5 million in 2024, then soared by 104.71% to $516.9 million in 2025, then grew by 13.89% to $588.7 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $588.7 million, $544.7 million, and $516.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 588.70 Mn |
| Mar 31, 2026 | 544.70 Mn |
| Dec 31, 2025 | 516.90 Mn |
| Sep 30, 2025 | 306.50 Mn |
| Jun 30, 2025 | 306.40 Mn |
| Mar 31, 2025 | 283.10 Mn |
| Dec 31, 2024 | 252.50 Mn |
| Sep 30, 2024 | 261.70 Mn |
| Jun 30, 2024 | 249.00 Mn |
| Mar 31, 2024 | 234.10 Mn |
| Dec 31, 2023 | 240.30 Mn |
| Sep 30, 2023 | 190.40 Mn |
| Jun 30, 2023 | 167.60 Mn |
| Mar 31, 2023 | 159.60 Mn |
| Dec 31, 2022 | 140.90 Mn |
| Sep 30, 2022 | 153.10 Mn |
| Jun 30, 2022 | 154.10 Mn |
| Mar 31, 2022 | 153.50 Mn |
| Dec 31, 2021 | 135.20 Mn |
| Sep 30, 2021 | 114.30 Mn |